Humanigen, Inc., a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, announced...
Alentis Therapeutics, AG announced it has dosed the first cohort of healthy participants in a first-in-human Phase 1 clinical trial of ALE.F02, a monoclonal...
Onera Health announced Improved Pharma Contributes to Paper Advancing the Study of Sameness of Amorphous Materialsthe introduction of its first Onera Biomedical-Lab-on-Chip™. The biomedical...
OLEDWorks, the leading global manufacturer of OLED lighting technology for automotive applications announces their participation as an exhibitor at CES 2022 located in Tech...
APi Group Corporation announced that it has completed its previously announced acquisition of the Chubb fire and security business (“Chubb”) from Carrier Global Corporation...
